Skip To Main Content
Ruiying Wu on Muck Rack

Ruiying Wu

As seen in: ACS Publications, Royal Society of Chemistry, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ruiying

Contact Ruiying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines

|
By Ruiying Wu, Huixin Li, Ziqin Li, Kai Hao
| Royal Society of Chemistry Verified
Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines mRNA-based cancer vaccines have emerged as a transformative immunotherapy, with dendritic cells (DCs) serving as pivotal orchestrators of innate and adaptive antitumor immunity. This review explores how DCs function as immunological bridges to enhance mRNA vaccine efficacy by integrating antigen presentation with coordinated immune cell crosstalk.
Open in Who Shared Issue with article?

Yiqi Yangyin Tongluo Recipe can alleviate diabetes nephropathy through

|
By Ruiying Wu, Tingting Chen, Yan Zhang, Rucui Yu
| Dove Medical Press
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 18 Original Research Diabetes Pathophysiology and Complications Authors Yu R, Wu R, Chen T, Zhang Y, Chen X Received 19 February 2025 Accepted for publication 19 June 2025 Published 28 June 2025 Volume 2025:18 Pages 2041—2055 DOI https://doi.org/10.2147/DMSO.S523784 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Rebecca Conway Rucui Yu,1 Ruiying...
Open in Who Shared Issue with article?

Self‐Supplied Reactive Oxygen Species‐Responsive Mitoxantrone Polyprodrug for Chemosensitization‐Enhanced Chemotherapy Under Moderate Hyperthermia

|
By Hongjie Zhang, Jing Wang, Ruiying Wu
| pericles.pericles-prod.literatumonline.com
Currently, the secondary development and modification of clinical drugs has become one of the research priorities. Researchers have developed a variety of TME-responsive nanomedicine carriers to solve certain clinical problems.
Open in Who Shared Issue with article?
See all 4 articles